Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF

PHASE3CompletedINTERVENTIONAL
Enrollment

1,332

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

September 30, 2011

Conditions
Infertility
Interventions
DEVICE

Test culture

A standard culture medium with added GM-CSF (ready-to-use)

DEVICE

Control culture

The same standard culture medium, but without any additions (ready-to-use)

Trial Locations (14)

2100

Rigshospitalet, Fertilitetsklinikken afd. 4071, Copenhagen

2650

Hvidovre Hospital; Fertilitetsklinikken afd. 455, Hvidovre

2730

Herlev Hospital, Fertilitetsklinikken G114F, Herlev

4300

Holbæk Sygehus, Fertilitetsklinikken, Holbæk

5000

Odense Universitets Hospital, Fertilitetsklinikken, Odense

7000

IVF-SYD, Fredericia

7800

Regionshospitalet Skive, Fertilitetsklinikken, Skive

8200

Maigaard Fertilitetsklinik, Aarhus

8270

Ciconia Aarhus Privathospital, Fertilitetsklinikken, Aarhus

8740

Brædstrup Sygehus; IVF-Klinikken, Brædstrup

9330

Fertilitetsklinikken Dronninglund, Dronninglund

14186

Karolinska Universitetssjukhuset Huddinge, Fertilitetsenheten K59, Stockholm

205 12

IVF Kliniken Öresund, Malmo

751 85

Reproduktionscentrum, Uppsala

All Listed Sponsors
lead

Origio A/S

INDUSTRY

NCT00565747 - Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF | Biotech Hunter | Biotech Hunter